DEFY

EXPECTATIONS

Challenge treatment goals

 

RHEUMATOLOGY

for moderate to severe adult TNFi-IR patients

for adult TNFi-IR patients

NOW APPROVED

for adult TNFi-IR patients

for adult TNFi-IR patients

Limitations of Use: Use of RINVOQ in combination with other JAK inhibitors, biologic DMARDs, or with potent immunosuppressants, such as azathioprine and cyclosporine, is not recommended.

 

DERMATOLOGY

for moderate to severe patients 12+ years not adequately controlled with other systemic drug products, including biologics

Limitations of Use: RINVOQ is not recommended for use in combination with other JAK inhibitors, biologic immunomodulators, or with other immunosuppressants.

 

GASTROENTEROLOGY

for moderate to severe adult TNFi-IR patients

Limitations of Use: RINVOQ is not recommended for use in combination with other JAK inhibitors, biological therapies for ulcerative colitis, or with other potent immunosuppressants such as azathioprine and cyclosporine.

RINVOQ® Complete logo.

RINVOQ Complete offers patients the resources and support they need
to start and stay on track with RINVOQ as prescribed.

Questions? Call 1.877.COMPLETE
(1.877.266.7538)

IR=intolerance or inadequate response; TNFi=tumor necrosis factor inhibitor.